172 related articles for article (PubMed ID: 36993223)
1. Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.
Twentyman J; Khalifeh A; Felton AL; Emerman M; OhAinle M
bioRxiv; 2023 Mar; ():. PubMed ID: 36993223
[TBL] [Abstract][Full Text] [Related]
2. Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.
Twentyman J; Khalifeh A; Felton AL; Emerman M; Ohainle M
Retrovirology; 2023 Aug; 20(1):15. PubMed ID: 37608289
[TBL] [Abstract][Full Text] [Related]
3. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
Ohainle M; Kim K; Komurlu Keceli S; Felton A; Campbell E; Luban J; Emerman M
PLoS Pathog; 2020 Apr; 16(4):e1008507. PubMed ID: 32282853
[TBL] [Abstract][Full Text] [Related]
4. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
Ohmine S; Sakuma R; Sakuma T; Thatava T; Takeuchi H; Ikeda Y
PLoS One; 2011 Jan; 6(1):e16121. PubMed ID: 21264255
[TBL] [Abstract][Full Text] [Related]
5. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races.
Tenthorey JL; Young C; Sodeinde A; Emerman M; Malik HS
Elife; 2020 Sep; 9():. PubMed ID: 32930662
[TBL] [Abstract][Full Text] [Related]
6. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
Kim J; Tipper C; Sodroski J
J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-sensitivity mutations in a Trim5-resistant primary isolate of pathogenic SIV identify two independent conserved determinants of Trim5α specificity.
McCarthy KR; Schmidt AG; Kirmaier A; Wyand AL; Newman RM; Johnson WE
PLoS Pathog; 2013 May; 9(5):e1003352. PubMed ID: 23675300
[TBL] [Abstract][Full Text] [Related]
8. TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys.
Lim SY; Rogers T; Chan T; Whitney JB; Kim J; Sodroski J; Letvin NL
PLoS Pathog; 2010 Jan; 6(1):e1000738. PubMed ID: 20107597
[TBL] [Abstract][Full Text] [Related]
9. TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
Wu F; Ourmanov I; Riddick N; Matsuda K; Whitted S; Plishka RJ; Buckler-White A; Starost MF; Hirsch VM
J Virol; 2015 Feb; 89(4):2233-40. PubMed ID: 25473059
[TBL] [Abstract][Full Text] [Related]
10. TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure.
Fenizia C; Keele BF; Nichols D; Cornara S; Binello N; Vaccari M; Pegu P; Robert-Guroff M; Ma ZM; Miller CJ; Venzon D; Hirsch V; Franchini G
J Virol; 2011 Dec; 85(23):12399-409. PubMed ID: 21917950
[TBL] [Abstract][Full Text] [Related]
11. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
Kahl CA; Cannon PM; Oldenburg J; Tarantal AF; Kohn DB
Gene Ther; 2008 Aug; 15(15):1079-89. PubMed ID: 18385767
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
Langelier CR; Sandrin V; Eckert DM; Christensen DE; Chandrasekaran V; Alam SL; Aiken C; Olsen JC; Kar AK; Sodroski JG; Sundquist WI
J Virol; 2008 Dec; 82(23):11682-94. PubMed ID: 18799573
[TBL] [Abstract][Full Text] [Related]
14. TRIM5α and Species Tropism of HIV/SIV.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():13. PubMed ID: 22291694
[TBL] [Abstract][Full Text] [Related]
15. A Potent Postentry Restriction to Primate Lentiviruses in a Yinpterochiropteran Bat.
Morrison JH; Miller C; Bankers L; Crameri G; Wang LF; Poeschla EM
mBio; 2020 Sep; 11(5):. PubMed ID: 32934084
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary and Functional Analysis of Old World Primate TRIM5 Reveals the Ancient Emergence of Primate Lentiviruses and Convergent Evolution Targeting a Conserved Capsid Interface.
McCarthy KR; Kirmaier A; Autissier P; Johnson WE
PLoS Pathog; 2015 Aug; 11(8):e1005085. PubMed ID: 26291613
[TBL] [Abstract][Full Text] [Related]
17. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection.
Li Y; Li X; Stremlau M; Lee M; Sodroski J
J Virol; 2006 Jul; 80(14):6738-44. PubMed ID: 16809279
[TBL] [Abstract][Full Text] [Related]
18. Unique features of TRIM5alpha among closely related human TRIM family members.
Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J
Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811
[TBL] [Abstract][Full Text] [Related]
19. Role of Human TRIM5α in Intrinsic Immunity.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():97. PubMed ID: 22435067
[TBL] [Abstract][Full Text] [Related]
20. African green monkey TRIM5α restriction in simian immunodeficiency virus-specific rhesus macaque effector CD4 T cells enhances their survival and antiviral function.
Jain S; Trivett MT; Ayala VI; Ohlen C; Ott DE
J Virol; 2015 Apr; 89(8):4449-56. PubMed ID: 25653448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
